The discovery of genes that have been proven to be of clinical relevance such as the Her2/neu gene in breast cancer and epidermal growth factor 1 (EGFR1) in non-small cell lung cancer has intensified interest in this area. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.